I.M. Sechenov First Moscow State Medical University (Sechenov University)
NCT05319340 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 1000
Last updated 2022-04-08
Summary
Single-institution uncontrolled open-label trial.
Conditions
- Anticoagulants
Interventions
- OTHER
-
prescribing anticoagulant therapy
Patients who need anticoagulants were consulted by a cardiologist with subsequent recommendations
Sponsors & Collaborators
-
I.M. Sechenov First Moscow State Medical University
lead OTHER
Principal Investigators
-
Zukhra Salpagarova · I.M. Sechenov First Moscow State Medical University (Sechenov University)
Study Design
- Allocation
- NA
- Purpose
- TREATMENT
- Masking
- NONE
- Model
- SINGLE_GROUP
Eligibility
- Min Age
- 18 Years
- Max Age
- 120 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2014-01-15
- Primary Completion
- 2021-03-02
- Completion
- 2021-03-02
More Related Trials
-
The Impact of Continuous Renal Replacement Therapy on the Outcomes of Burn Patients With Early Phase of Sepsis
NCT01501097 ·Status: UNKNOWN ·Phase: NA
-
Statin for Immunomudulation in Sepsis
NCT00452608 ·Status: UNKNOWN ·Phase: PHASE2
-
Procalcitonin to Shorten Antibiotics Duration in ICU Patients
NCT01379547 ·Status: UNKNOWN ·Phase: PHASE3
-
Safety and Efficiency of Combined Extracorporeal Blood Purification in Neurosurgical ICU. Prospective RCT
NCT04152174 ·Status: UNKNOWN ·Phase: NA
-
Russian Clinical Trial of Mesenchymal Cells in Patients With Septic Shock and Severe Neutropenia
NCT01849237 ·Status: UNKNOWN ·Phase: PHASE1/PHASE2
-
Efficacy and Safety of Kukoamine B Mesilate in Sepsis Patients
NCT04803955 ·Status: RECRUITING ·Phase: PHASE2
-
Prolonged Intravenous Infusion of β-lactam Antibiotics in Early Septic Patients
NCT05024565 ·Status: UNKNOWN ·Phase: NA
-
Procalcitonin Monitoring May Decrease Antibiotic Use in the Intensive Care Unit
NCT01085994 ·Status: UNKNOWN
-
Immune Function Monitoring and Immunotherapy in Sepsis
NCT04903405 ·Status: UNKNOWN
-
Study the Impact of Statins in Septic Shock
NCT02681653 ·Status: COMPLETED ·Phase: NA
-
Sepsis in Neutropenic Patients: Autologous Stem Cell Transplantation as Model: a Transcriptomic Approach
NCT01693952 ·Status: UNKNOWN ·Phase: NA
-
Effect of Renin-Angiotensin System on Platelet in Patient With Sepsis
NCT03952390 ·Status: COMPLETED
-
The Predictive Value of Hepatocyte Growth Factor and Soluble Receptor s-Met in Sepsis
NCT03340649 ·Status: UNKNOWN
-
Preliminary Research On Two-step Dosing Of Imipenem/Cilastatin
NCT02616354 ·Status: UNKNOWN ·Phase: PHASE4
-
Efficacy of Anisodamine Hydrobromide Combined With Low-molecular-weight Heparin in the Treatment of Patients With Sepsis
NCT05634057 ·Status: RECRUITING ·Phase: NA
-
Impact of 30 mg/kg Amikacin and 8 mg/kg Gentamicin on Serum Concentrations in Critically Ill Patients With Severe Sepsis
NCT02898961 ·Status: COMPLETED ·Phase: PHASE4
-
Continuos Terlipressin Infusion in Septic Shock
NCT01697410 ·Status: UNKNOWN ·Phase: NA
-
A Prospective Observational Study of Sepsis
NCT05309889 ·Status: UNKNOWN
-
Efficacy of Melatonin in Patients With Severe Sepsis or Septic Shock
NCT01858909 ·Status: UNKNOWN ·Phase: PHASE3
-
Safety and Efficacy of Procalcitonin Guided Antibiotic Therapy in Adult Intensive Care Units (ICU's)
NCT01139489 ·Status: COMPLETED ·Phase: NA
-
Outcome Predictors in Patients With Severe Sepsis and Optimized Central Venous Oxygen Saturation
NCT01362829 ·Status: COMPLETED
-
Procurement of Human Specimens for the Evaluation of Early Markers of Sepsis
NCT01746407 ·Status: COMPLETED
-
Integrated Clinical Decision Support for Empiric Antibiotic Selection in Sepsis
NCT06103500 ·Status: RECRUITING ·Phase: NA
-
Effects of Chronic Antihypertensive Therapy on Clinical Outcomes in Septic Shock
NCT02876341 ·Status: COMPLETED
-
The Effect of Ketanserin on the Microcirculation in Sepsis
NCT01329887 ·Status: COMPLETED ·Phase: PHASE3